This Project Grant award of $2,000,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493) will establish the Wisconsin Opioid Overdose Response Center and Pharmacy Resource Network at the University of Wisconsin-Madison. The primary objectives of this initiative are to: Increase patient access to evidence-based treatments for opioid use disorder and overdose through expanded community pharmacy-based services across...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Hawaii Department of Health Alcohol and Drug Abuse Division (ADAD) a $24,000,000 State Opioid Response (SOR) Project Grant (CFDA 93.243) to address opioid and stimulant use, misuse, and overdose in Hawaii. The 3-year Hawaii SOR 4 project aims to expand access to substance use disorder (SUD) treatment and recovery support services, reaching at least 900 individuals through improved telehealth implementation. The...
The Oregon Health Authority (OHA) received a $45,830,769 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, known as the Oregon State Opioid Response (SOR) 4 Grant, will fund a comprehensive set of activities to address substance use disorders, overdose prevention, harm reduction, treatment, recovery support,...
The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $16,281,088 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the South Dakota Department of Social Services, Division of Behavioral Health. The grant, titled "SOUTH DAKOTA'S STATE OPIOID RESPONSE (SOR 2024)," will expand upon existing infrastructure and capacity to...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Colorado Behavioral Health Administration's Adult Recovery and Treatment Team a $83,223,540 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. This funding supports the Colorado State Opioid Response (CO-SOR) program, which aims to serve nearly 4 million Coloradans over 3 years through a variety of anti-stigma campaigns,...
The North Dakota Department of Human Services (NDDHS) was awarded a $16,000,000 State Opioid Response (SOR) grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The grant, spanning September 30, 2024 to September 29, 2027, aims to address the opioid overdose crisis in North Dakota by increasing access to medication for opioid use disorder...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $54,004,380 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Louisiana Department of Health's (LDH) Office of Behavioral Health (OBH) Division. The Louisiana State Opioid Response (LASOR) 4.0 program will enhance statewide prevention, treatment, and recovery support services for individuals with or at risk for opioid use...
The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $12,000,000 Project Grant to the Wyoming Department of Health. This grant, titled the "Wyoming State Opioid Response Project (WYSOR)", aims to enhance access to opioid use disorder (OUD) treatment, focusing on coordinated care, recovery support services, and...
The Utah State Opioid Response Grant (UT SOR4) is a $32,106,465 project grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant aims to prevent and reduce opioid and stimulant use among youth, adults, and at-risk populations in Utah, including tribal populations and uninsured/underinsured individuals. Key strategies include expanding...
This $400,907,000 Project Grant, awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR (CFDA 93.788) federal grant program, supports Ohio's comprehensive State Opioid and Stimulant Response (SOS) initiative. The funding aims to flatten Ohio's opioid and drug overdose death rate, increase access to harm reduction, expand evidence-based practices, and promote behavioral wellness for 35,000 Ohio youth and adults. Key services delivered through this...
The Wisconsin State Opioid Response (SOR) Grant, awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance, provides $71,160,580 to expand access to evidence-based opioid and stimulant use disorder treatment and recovery services, advance prevention and harm reduction, and reduce overdose deaths. The award aims to support 120,000 individuals with substance use and overdose prevention services, 3,600 with treatment services, and 3,000 with recovery support services. Key initiatives include distributing naloxone, expanding access to medication-assisted treatment, training emergency department clinicians, and implementing targeted media campaigns. Sub-awards support tribal communities, rural areas, and diverse populations through partnerships with local government entities, tribal organizations, and non-profit providers.